BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bordeaux Neurocampus - ECPv4.9.10//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bordeaux Neurocampus
X-ORIGINAL-URL:https://www.bordeaux-neurocampus.fr/en/
X-WR-CALDESC:Events for Bordeaux Neurocampus
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20250314T140000
DTEND;TZID=Europe/Paris:20250314T140000
DTSTAMP:20260422T022134
CREATED:20241216T131809Z
LAST-MODIFIED:20250219T181629Z
UID:178903-1741960800-1741960800@www.bordeaux-neurocampus.fr
SUMMARY:Thesis defense - Sara Carracedo
DESCRIPTION:Venue: Centre Broca \n \nThesis defended in english \n\nSara Carracedo\nIMN\nThesis directed by Eric Boue-Grabot \nTitle\nNeuronal and microglial function of P2X4 receptor in Amyotrophic lateral sclerosis and its potential use as a biomarker \nAbstract\nAmyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the progressive degeneration of motor neurons (MNs)\, driven by misfolded protein aggregation and neuroimmune dysregulation. P2X4 receptor\, an ATP-gated ion channel expressed in neurons and glial cells\, has emerged as a key player in ALS pathogenesis. Under normal conditions\, P2X4 is primarily internalized\, maintaining low surface expression. However\, in pathological states such as ALS\, P2X4 is increasingly localized to the cell surface. \nUsing double-transgenic SOD1 G93A (SOD1) mice expressing either an internalization-defective P2X4-mCherryIN knock-in or invalidated for the P2X4 gene\, it was reported that both the increase in surface P2X4 and its absence improved disease outcomes. These findings suggest complex cell-specific roles of P2X4 receptor\, which remains unexplored. Thus\, this study aims to investigate the distinct neuronal and microglial roles of the P2X4 receptor in ALS using triple-transgenic mice designed to selectively manipulate P2X4 expression in microglia/macrophages or neurons in the SOD1 mice model. \nOur results demonstrate that an increase in neuronal surface P2X4 accelerates ALS progression\, while its upregulation in microglia/macrophages slows disease progression. In microglia\, surface P2X4 mitigates immune overactivation in the spinal cord and reduces immune cell infiltration along MN axons in SOD1 mice. Consistent with this data\, cell-specific deletion of P2X4 had opposing effects on ALS progression: the absence of P2X4 in neurons was protective\, whereas its deletion in microglia/macrophages worsened disease outcomes. Altogether\, we found that neuronal and microglial P2X4 play dual and opposing roles in ALS pathophysiology. \nIn SOD1 mice\, elevated surface P2X4 expression was previously observed in peritoneal macrophages even before symptom onset. Translating this finding to humans\, we developed a flow cytometry-based method to measure the surface-to-total ratio of P2X4 in monocytes from peripheral blood samples. ALS patients\, particularly women\, exhibited significantly higher surface P2X4 levels in monocytes compared to patients with other neuromuscular diseases. This aberrant surface P2X4 expression was detected in both sporadic and familial forms of ALS\, regardless of whether the disease had a bulbar or lumbar onset\, underscoring the broad utility of P2X4 as a blood-based biomarker for ALS. \nIn conclusion\, our data reveal dual and opposing roles of neuronal and microglial P2X4 receptors in ALS progression and highlight its potential as both a therapeutic target and a diagnostic biomarker for ALS. \nKey words\n ALS\, P2X4\, Receptor trafficking\, Microglia\, Macrophages\, Immune response \nPublications\nCarracedo S\, Launay A\, Dechelle-Marquet PA\, Faivre E\, Delarasse C\, Blum D and Boué-Grabot E (2024) Purinergic-associated immune responses in neurodegenerative diseases (2024). Progress in Neurobiology. Vol 243\, 102693. \nGilabert D\, Duveau A\, Carracedo S\, Linck N\, Langla A\, Grutter T\, Muramatsu R\, Koch-Nolte F\, Fossat P\, Boué-Grabot E and Ulmann L (2023). Microglial P2X4 receptors are essential for spinal neurons hyperexcitability and tactile allodynia in male and female neuropathic mice. iScience: S2589-0042(23)02187-9. \nBertin E\, Martinez A\, Fayoux A\, Carvalho K\, Carracedo S\, Fernagut P\, Koch-Nolte F\, Blum D\, Bertrand S and Boué- Grabot E (2022). Increased surface P2X4 receptors by mutant SOD1 proteins contribute to ALS pathogenesis in SOD1-G93A mice. Cellular and Molecular Life Sciences 79(8):431. \nJury\nSéverine BOILLEE  DR\, CNRS\, Bordeaux Rapportrice \nBart EGGEN Examinateur\, University Medical Center Groningen\, The Netherlands \nPhilippe SEGUELA Raporteur Pr. McGill University\, Canada \nCecile DELARASSE  DR\, CNRS\, Paris\,  Examinatrice \nAgnes NADJAR Président Rapporteur \nSandrine BERTRAND  DR\, CNRS\, Bordeaux  Invitée \nGwendal LEMASSON\, DR\, INSERM\, Bordeaux\, Invitée \nEric BOUE-GRABOT  DR\, CNRS\, Bordeaux  Directeur de thèse \n
URL:https://www.bordeaux-neurocampus.fr/en/event/thesis-defense-sara-carracedo/
CATEGORIES:IMN,Thesis
END:VEVENT
END:VCALENDAR